Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	94.11	-3.53	-59.92
Graham Fair Price	218.04	62.13	19.54
PEG	-94.98	< 0.005	< 0.005
Price/Book	-57.85	-0.48	1.13
Price/Cash Flow	-79.23	1.31	-6.30
Prices/Earnings	81.21	-0.09	-0.49
Price/Sales	-62.04	0.08	0.21
Price/FCF	-79.23	1.31	-6.30
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	36.23	-0.10	0.07
Operating Margin	-212.11	-0.23	-0.07
ROA	-494.92	-0.18	-0.03
ROE	-0.57	1.28	124.25
ROIC	-0.05	-0.38	-691.92
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.03	< 0.005	506.53
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-11.75	-6.36	45.90
EPS QOQ	-1.01	-3.77	-274.43
FCF QOQ	0.71	5.31	650.55
Revenue QOQ	0.02	1.36	5739.42
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	35.50	18.59	-47.65
Days Sales Outstanding (DSO)	514.60	119.08	-76.86
Inventory Turnover	2.53	4.84	91.02
Debt/Capitalization	0.90	1.31	46.11
Quick Ratio	0.63	0.42	-33.04
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	5.45	-11.57	112.38
Cash	5.74	8.17	42.21
Capex	-1.43	-3.62	-153.57
Free Cash Flow	-0.98	4.21	330.92
Revenue	29.24	68.93	135.78
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.84	0.65	-23.30
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-52.51	-3.12	94.05
Naive Interpretation	Member

06 - Financial Health · Bad

Rating